Literature DB >> 12417810

Association of mannan-binding lectin deficiency with venous bypass graft occlusions in patients with coronary heart disease.

Vilho Limnell1, Janne Aittoniemi, Outi Vaarala, Terho Lehtimäki, Seppo Laine, Vesa Virtanen, Timo Palosuo, Ari Miettinen.   

Abstract

We investigated the effect of mannan-binding lectin (MBL) deficiency on the susceptibility to bypass graft occlusion in 62 patients with coronary heart disease. MBL deficiency appeared to be associated with occlusion (p = 0.0099). A high level of anti-cardiolipin IgG as well as the number of venous bypass grafts were also involved (p = 0.0018 and p = 0.0104, respectively). Since early occlusion (<5 years after surgery) of a venous bypass graft is considered to be caused by thrombosis or fibro-intimal hyperplasia superimposed by thrombosis, our finding also implies an association of MBL deficiency with thrombotic events. It remains unclear whether the previously confirmed effect of MBL deficiency in coronary disease is mediated through this possible thrombotic mechanism, or whether plaque formation is also involved in the process. Further studies are clearly warranted. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417810     DOI: 10.1159/000066313

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

1.  Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus.

Authors:  Liping Li; Chenxue Qu; Xuelian Wu; Juhua Dai; Yao Lu; Yan Gong; Ran You; Yaqi Liu
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

2.  Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia.

Authors:  Lawrence T Lai; Daniel C Lee; Wilson Ko; Ketan Shevde; Ming Zhang
Journal:  Int J Cardiol       Date:  2008-11-26       Impact factor: 4.164

Review 3.  Complement activation and cardiac surgery: a novel target for improving outcomes.

Authors:  Gregory L Stahl; Stanton K Shernan; Peter K Smith; Jerrold H Levy
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

4.  Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk.

Authors:  Saedis Saevarsdottir; Oskar Orn Oskarsson; Thor Aspelund; Gudny Eiriksdottir; Thora Vikingsdottir; Vilmundur Gudnason; Helgi Valdimarsson
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

5.  Association between low levels of Mannan-binding lectin and markers of autoimmune thyroid disease in pregnancy.

Authors:  Eliska Potlukova; Tomas Freiberger; Zdenka Limanova; Jan Jiskra; Zdenek Telicka; Jana Bartakova; Drahomira Springer; Hana Vitkova; Marten Trendelenburg
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

6.  Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Miklós Káplár; Shah Sweni; Julianna Kulcsár; Barbara Cogoi; Regina Esze; Sándor Somodi; Mária Papp; László Oláh; Mária Tünde Magyar; Katalin Szabó; Katalin Réka Czuriga-Kovács; Jolán Hársfalvi; György Paragh
Journal:  J Diabetes Res       Date:  2015-11-10       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.